Zoetis Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
3.0%projected annual EPS growth
Analyst Coverage
16analysts covering
FY EPS (est.)
$6.29next fiscal year
Monitoring Framework
Key Performance Indicators
Organic Operational Revenue Growth Quarterly2.0%Target: High single-digit growth (typically 5% to 7% annually)
U.S. Companion Animal Revenue Growth Quarterly-11.0%Target: Positive growth driven by Simparica Trio and OA Pain franchises
International Segment Organic Growth Quarterly8.0%Target: High single-digit growth to offset domestic softness
Renewable Electricity Sourced Annually0.3
Watch Items
- U.S. Companion Animal Segment CompetitionTrigger: Further double-digit organic revenue declines in U.S. companion animal productsAction: Re-evaluate marketing spend, pricing strategies, and promotional support for Simparica Trio and Librela franchises.
- Millennial and Gen Z Pet Owner Price SensitivityTrigger: Sustained drop in veterinary clinic traffic and wellness visitsAction: Expand lower-cost diagnostic options and adjust pricing tiers to capture budget-conscious consumers.
Research as of 2 Sep 2026